Royal Philips Receives FDA 510(k) Clearance For Philips Spectral CT Verida System, Bringing Next-Gen, AI-Powered Spectral CT Innovation To US
Benzinga Newsdesk 6 months ago
NewsFDA
Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncologyAmsterdam, the Netherlands – Royal
Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncology
Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, today announced it has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral CT Verida system, bringing its next-generation, AI-powered spectral CT innovation to the United States.
AI-based reconstruction integrated into the imaging chain
Verida incorporates Spectral Precise Image, with a third-generation Nano-panel Precise dual-layer detector with intrinsic noise reduction, along with an AI-based deep learning reconstruction engine, designed to reduce noise and enhance image quality across CT applications [1]. Clinicians are able to customize optimal image de-noising according to their preferences.